Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398918 · ClinicalTrials.gov registry record · NA
Alcohol Self Administration Laboratory
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00398918 is a NA study that has completed, run by Boston University. The registered enrollment target is 10 participants.
The verdict
NCT00398918, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a pilot study in which our intent is to establish an alcohol administration laboratory in which we will be able to test the effect of the anticonvulsant medication zonisamide as compared to placebo on alcohol self administration and on cognitive functioning in non treatment seeking heavy users of alcohol. Our first goal is to establish the safety of zonisamide when used together with alcohol. Our second goal is to test the effect of an acute dose of zonisamide on alcohol consumption and show that it may reduce the consumption of alcohol. To achieve this goal we seek subjects with a history of heavy drinking to be tested on the self-administration procedures described below in two sessions with either zonisamide or placebo. These procedures will involve first, the administration of a challenge dose of ethanol to evaluate the effect of alcohol on performance on neuropsychological tests. This initial challenge will be followed by a period of alcohol self-administration in which the research subject can choose to select either ethanol or another reinforcer, money.
Interventions
- DRUG Placebo
- DRUG zonisamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00398918
The ClinicalTrials.gov registry entry for NCT00398918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00398918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00398918 about?
NCT00398918 is a clinical study titled "Alcohol Self Administration Laboratory". This is a pilot study in which our intent is to establish an alcohol administration laboratory in which we will be able to test the effect of the anticonvulsant medication zonisamide as compared to placebo on alcohol self administration and on cognitive functioning in non treatment seeking heavy use...
What is the current status of trial NCT00398918?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2006-11. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00398918?
The interventions under investigation include: Placebo (DRUG), zonisamide (DRUG).
Who is sponsoring clinical trial NCT00398918?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.